KALA BIO, INC. Variable Lease, Cost
KALA BIO, INC. (KALA) reported Variable Lease, Cost of $179.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-04-15
- KALA BIO, INC. variable lease, cost for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- KALA BIO, INC. variable lease, cost for the quarter ending 2025-09-30 was $54.00K, a 10.20% increase year-over-year.
- KALA BIO, INC. variable lease, cost for the quarter ending 2025-06-30 was $54.00K, a 8.00% increase year-over-year.
- KALA BIO, INC. variable lease, cost for the quarter ending 2025-03-31 was $71.00K, a 18.33% increase year-over-year.
- KALA BIO, INC. variable lease, cost for fiscal 2025 was $179.00K, a 14.35% decline from fiscal 2024.
- KALA BIO, INC. variable lease, cost for fiscal 2024 was $209.00K, a 113.27% increase from fiscal 2023.
- KALA BIO, INC. variable lease, cost for fiscal 2023 was $98.00K, a 87.07% decline from fiscal 2022.
- KALA BIO, INC. variable lease, cost for fiscal 2022 was $758.00K, a 66.61% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $54.00K derived: sum of 2 quarters · filed 2026-04-15 | $108.00K derived: sum of 3 quarters · filed 2026-04-15 | $179.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $54.00K 10-Q · filed 2025-11-19 | $108.00K derived: sum of 2 quarters · filed 2025-11-19 | $179.00K 10-Q · filed 2025-11-19 | $229.00K derived: sum of 4 quarters · filed 2026-04-15 |
| 2025-06-30 | $54.00K 10-Q · filed 2025-08-08 | $125.00K 10-Q · filed 2025-08-08 | $175.00K derived: sum of 3 quarters · filed 2026-04-15 | $224.00K derived: sum of 4 quarters · filed 2026-04-15 |
| 2025-03-31 | $71.00K 10-Q · filed 2025-05-14 | $121.00K derived: sum of 2 quarters · filed 2026-04-15 | $170.00K derived: sum of 3 quarters · filed 2026-04-15 | $220.00K derived: sum of 4 quarters · filed 2026-04-15 |
| 2024-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $99.00K derived: sum of 2 quarters · filed 2026-04-15 | $149.00K derived: sum of 3 quarters · filed 2026-04-15 | $209.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $49.00K 10-Q · filed 2025-11-19 | $99.00K derived: sum of 2 quarters · filed 2025-11-19 | $159.00K 10-Q · filed 2025-11-19 | $205.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-06-30 | $50.00K 10-Q · filed 2025-08-08 | $110.00K 10-Q · filed 2025-08-08 | $156.00K derived: sum of 3 quarters · filed 2025-08-08 | $202.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $60.00K 10-Q · filed 2025-05-14 | $106.00K derived: sum of 2 quarters · filed 2025-05-14 | $152.00K derived: sum of 3 quarters · filed 2025-05-14 | $152.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $92.00K derived: sum of 2 quarters · filed 2025-03-31 | $92.00K derived: sum of 3 quarters · filed 2025-03-31 | $98.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $46.00K 10-Q · filed 2024-11-12 | $46.00K derived: sum of 2 quarters · filed 2024-11-12 | $52.00K 10-Q · filed 2024-11-12 | $70.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $6.00K 10-Q · filed 2024-08-06 | $24.00K derived: sum of 3 quarters · filed 2024-08-06 | $138.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $6.00K 10-Q · filed 2024-05-14 | $24.00K derived: sum of 2 quarters · filed 2024-05-14 | $138.00K derived: sum of 3 quarters · filed 2024-05-14 | $317.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $132.00K derived: sum of 2 quarters · filed 2024-03-29 | $311.00K derived: sum of 3 quarters · filed 2024-03-29 | $758.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $114.00K 10-Q · filed 2023-11-13 | $293.00K derived: sum of 2 quarters · filed 2023-11-13 | $740.00K 10-Q · filed 2023-11-13 | $1.39M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $179.00K 10-Q · filed 2023-08-04 | $626.00K 10-Q · filed 2023-08-04 | $1.27M derived: sum of 3 quarters · filed 2023-08-04 | $1.80M derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $447.00K 10-Q · filed 2023-05-09 | $1.10M derived: sum of 2 quarters · filed 2023-05-09 | $1.62M derived: sum of 3 quarters · filed 2023-05-09 | $2.21M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $649.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $1.18M derived: sum of 2 quarters · filed 2023-03-03 | $1.76M derived: sum of 3 quarters · filed 2023-03-03 | $2.27M 10-K · filed 2023-03-03 |
| 2021-09-30 | $528.00K 10-Q · filed 2022-11-08 | $1.11M derived: sum of 2 quarters · filed 2022-11-08 | $1.62M 10-Q · filed 2022-11-08 | $2.00M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $584.00K 10-Q · filed 2022-08-11 | $1.09M 10-Q · filed 2022-08-11 | $1.47M derived: sum of 3 quarters · filed 2022-08-11 | $1.87M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $509.00K 10-Q · filed 2022-05-16 | $885.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.29M derived: sum of 3 quarters · filed 2022-05-16 | $1.95M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $780.00K derived: sum of 2 quarters · filed 2022-03-29 | $1.44M derived: sum of 3 quarters · filed 2022-03-29 | $1.85M 10-K · filed 2022-03-29 |
| 2020-09-30 | $404.00K 10-Q · filed 2021-11-15 | $1.06M derived: sum of 2 quarters · filed 2021-11-15 | $1.47M 10-Q · filed 2021-11-15 | $2.36M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $658.00K 10-Q · filed 2021-08-05 | $1.07M 10-Q · filed 2021-08-05 | $1.95M derived: sum of 3 quarters · filed 2021-08-05 | $2.32M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $410.00K 10-Q · filed 2021-05-05 | $1.29M derived: sum of 2 quarters · filed 2021-05-05 | $1.67M derived: sum of 3 quarters · filed 2021-05-05 | $2.05M derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $884.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.25M derived: sum of 2 quarters · filed 2021-02-25 | $1.64M derived: sum of 3 quarters · filed 2021-02-25 | $1.77M 10-K · filed 2021-02-25 |
| 2019-09-30 | $371.00K 10-Q · filed 2020-11-05 | $754.00K derived: sum of 2 quarters · filed 2020-11-05 | $882.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $383.00K 10-Q · filed 2020-08-06 | $507.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $124.00K 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | $83.00K 10-K · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |